US2017216369A1PendingUtilityA1
Wound healing compositions involving medicinal honey, mineral ions and methylglyoxal, and methods of use
Individually held — no corporate assignee on recordPriority: Jan 29, 2015Filed: Oct 26, 2016Published: Aug 3, 2017
Est. expiryJan 29, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 29/00A61P 17/02A61K 31/11A61K 35/644A61L 15/46A61L 2300/404A61L 2300/216A61L 15/40A61L 26/0057A61K 33/06A61K 33/30A61K 33/00A61K 33/04A61K 9/0014A61L 15/20A61K 31/121A61L 26/0066A61L 2300/30A61L 2300/102
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides compositions based on either medicinal honey containing broad spectrum antibacterial activities of peroxide, polyphenols and methylglyoxal, or an effective amount of an active anti-inflammatory ingredient of mineral solids fortified with methylglyoxal antibacterial activity, or a mixture of both for the treatment of wounds; and methods of treating a wound, comprising contacting a wound with any one of the above compositions or a wound dressing containing any one of the above compositions.
Claims
exact text as granted — not AI-modified1 . A wound healing composition, comprising:
a medicinal honey; and a concentration of methylglyoxal being added to said medicinal honey effective to reduce a number of viable microorganisms at a wound site.
2 . The wound healing composition of claim 1 , wherein the medicinal honey naturally contains or generates 2-4 mM hydrogen peroxide upon dilution with an aqueous medium.
3 . The wound healing composition of claim 1 , wherein the medicinal honey naturally contains a polyphenol concentration ranging between 275 and 575 gallic acid equivalents per gram of the medicinal honey.
4 . The composition of claim 1 , wherein the medicinal honey is buckwheat honey.
5 . The composition of claim 1 , wherein said concentration of methylglyoxal ranges from 500 to 2000 mg per kg.
6 . The wound healing composition of claim 1 , wherein the wound healing composition is replaced on a wound at least once.
7 . A wound healing composition, comprising:
a pharmaceutically acceptable carrier; an effective amount of an active ingredient of mineral solids, said mineral solids including at least one of a magnesium salt, a potassium salt, a calcium salt, a zinc salt, a rubidium salt, a bromide salt, and a sulfate salt; and a concentration of methylglyoxal effective to reduce a number of microorganisms at a wound site being added to said active ingredient.
8 . The wound healing composition of claim 7 , wherein each of the salts includes a pharmaceutically-acceptable counterion.
9 . The wound healing composition of claim 7 , wherein the active ingredient of mineral solids includes 1.5-75 parts of magnesium ions, 0.5-75 parts of potassium ions, 0.001-10 parts of calcium ions, 0.0001-10 parts of zinc ions, up to 5 parts of rubidium ions, 0.001-20 parts of bromide ions, and up to 20 parts of sulfate ions, said parts expressing a mass of a respective ions divided by a total mass of the mineral solids.
10 . The wound healing composition of claim 7 , wherein said methylglyoxal added to said active ingredient ranges from 500 to 2000 mg/kg of the composition.
11 . The wound healing composition of claim 7 , wherein the pharmaceutically-acceptable carrier includes at least one of water, polyethylene glycol, an ointment, and a cream base.
12 . The wound healing composition of claim 7 , wherein a pH of the composition is between 3.0-7.0.
13 . The wound healing composition of claim 7 , wherein the wound healing composition is replaced on a wound at least once.
14 . A wound healing composition, comprising:
a first would healing composition, including:
a medicinal honey; and
a concentration of methylglyoxal being added to said medicinal honey effective to reduce a number of viable microorganisms at a wound site;
a second wound healing composition, including:
a pharmaceutically acceptable carrier;
an effective amount of an active ingredient of mineral solids, said mineral solids including at least one of a magnesium salt, a potassium salt, a calcium salt, a zinc salt, a rubidium salt, a bromide salt, and a sulfate salt; and
a concentration of methylglyoxal effective to reduce a number of microorganisms at a wound site being added to said active ingredient; and
a ratio of a volume of said first wound healing composition to a volume of said second wound healing composition being between 1:9 and 9:1.
15 . A wound healing dressing, comprising:
the wound healing composition according to claim 1 ; and a support.
16 . A wound healing dressing, comprising:
the wound healing composition according to claim 7 ; and a support.
17 . A wound healing dressing, comprising:
the wound healing composition according to claim 14 ; and a support.
18 . The wound healing dressing of claim 15 , wherein the support includes at least one of a fibrous gauze material, a hydrogel, a foam, a film, a hydrocolloid, a collagen, and an alginate.
19 . A method of treating a wound, which comprises contacting a wound with the composition of claim 1 .
20 . A method of treating a wound, which comprises contacting a wound with the wound dressing of claim 15 .
21 . The wound healing composition of claim 14 , wherein the wound healing composition is replaced on a wound at least once.Join the waitlist — get patent alerts
Track US2017216369A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.